{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T06:28:33Z","timestamp":1716359313027},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T00:00:00Z","timestamp":1235088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background:<\/jats:italic> Psoriasis vulgaris is one of the most common dermatologic diseases in Germany with a prevalence of about 2%. Along with efficacy and safety, costs are an important criterion for selecting appropriate therapy for this chronic disease. The majority of the patients with mild to moderate psoriasis vulgaris can be successfully treated with topical therapy alone. The most important agents are vitamin D<jats:sub>3<\/jats:sub> analogs and corticosteroids either as single agents or in a fixed combination (Daivobet<jats:sup>\u00ae<\/jats:sup>).<\/jats:p><jats:p> <jats:italic>Methods:<\/jats:italic> For the evaluation of the cost\u2010effectiveness of different topical psoriasis treatments, a Markov model was developed that compares a fixed combination treatment followed by calcipotriol with a morning\/evening application of the individual agents, as well as a comparison with tacalcitol.<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> The pharmacoeconomic evaluation showed a higher cost\u2010effectiveness of the fixed combination treatment compared to using single agents (morning\/evening) and to the tacalcitol. Treatment with the fix combination is more effective and more economic. Additional sensitivity analyses demonstrated that the advantage remains even when assuming a maximum compliance for twice daily usage, and varying the effectiveness of the fixed combination by 10%.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> The treatment of mild to moderate psoriasis with a fixed calcipotriol\/betamethasone combination is a more cost\u2010effective treatment than a treatment with the single agents or tacalcitol monotherapy.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2008.06919.x","type":"journal-article","created":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T07:58:12Z","timestamp":1235116692000},"page":"329-338","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany"],"prefix":"10.1111","volume":"7","author":[{"given":"Matthias","family":"Augustin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Van Engen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Ruedig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Lapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Moehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503023320907"},{"key":"e_1_2_6_3_2","unstructured":"AugustinM SchaeferI RustenbachSJ ZimmerL.Prevalence of skin diseases in a cohort of 48 665 employees in Germany(submitted2007)."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031120"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117046"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069029"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02461.x"},{"key":"e_1_2_6_8_2","first-page":"S55","article-title":"Topical application of calcipotriene and corticosteroids: combination regimens","volume":"37","author":"Lebwohl M","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1148.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405060-00012"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066440"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.130"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948194"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05986.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07236.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000096069"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06174.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017972"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119669"},{"key":"e_1_2_6_20_2","volume-title":"Gesundheitsbe\u2010richterstattung des Bundes. Heft 11: Psoriasis","author":"Traupe H","year":"2002"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000090654"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2005.05729.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106791"},{"key":"e_1_2_6_24_2","first-page":"225","volume-title":"Pharmako\u00f6konomie in Deutschland","author":"Von Der Schulenburg JM","year":"1995"},{"key":"e_1_2_6_25_2","unstructured":"LEO Pharma. Medical departments. MCB 0001 INT clinical study report. Calcipotriol\/betamethasone once daily versus tacalcitol once daily in psoriasis vulgaris. A phase IIIb study with pharmacoeconomic evaluation comparing two treatment regimes in psoriasis vulgaris: i\/combination ointment of calcipotriol 50 \u03bcg\/g plus betamethasone dipropionate 0.5 mg\/g once daily for 4 weeks followed by calcipotriol ointment 50 \u03bcg\/g once daily for 4 weeks with ii\/ Tacalcitol ointment 4 \u03bcg\/g once daily for 8 weeks: 26 November 2002."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080854"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000086444"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02461.x"},{"key":"e_1_2_6_29_2","unstructured":"Hart\u2010HansenK KjaerT.Eliciting preferences for topical treatment of Psoriasis \u2013An application of the discrete choice experiment.MSc. Thesis for Health Economics The faculty of Life science University of Copenhagen Copenhagen 25 April 2003(unpublished)."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018050-00006"},{"key":"e_1_2_6_31_2","unstructured":"MortonCA MoraisJC.Topical combination calcipotriol\/betamethasone dipropionate prior to phototherapy in psoriasis \u2013 A cost\u2010effective strategy?[PO35.90] 15th Congress of the European Academy of Dermatology and Venereology 4\u20138 October 2006 Rhodos Griechenland ."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(10)61998-5"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2008.06919.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2008.06919.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:21:26Z","timestamp":1697440886000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2008.06919.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,30]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1610-0387.2008.06919.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2008.06919.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,30]]}}}